The Polite Illusion of Algorithmic Help
AI health assistants and medical chatbots—digital systems designed to interpret symptoms, explain insurance benefits, and guide treatment decisions—are rapidly moving ...
When Appetite Becomes Optional
Glucagon-like peptide-1 receptor agonists—marketed most visibly as Ozempic and Wegovy—have moved from endocrinology clinics into popular culture with unusual velocity. ...
The Generation That Grew Up Online
Between 2010 and 2015, smartphones became nearly ubiquitous among adolescents in the United States. By 2022, the Pew Research Center ...
When Distrust Becomes Identity
Vaccine hesitancy in the United States has shifted from episodic skepticism to a more durable cultural posture, reshaping immunization coverage ...
When Exhaustion Loses Its Prestige
Sleep deprivation, once a tacit credential in medicine, finance, and technology, is increasingly recast as risk rather than dedication. Accumulating ...
The Ingredient Wars
Seed oils, emulsifiers, stabilizers, preservatives—once obscure inputs in a globalized food system—now serve as ideological flashpoints. The term “ultra-processed food,” ...
When the Taboo Becomes Therapeutic
Psilocybin, MDMA, and ketamine—substances long relegated to the margins of medicine—are advancing through clinical trials with growing institutional legitimacy. The ...
When Geography Governs the Body
When the Supreme Court issued its decision in <em>Dobbs v. Jackson Women’s Health Organization</em> in 2022, overturning <em>Roe v. Wade</em> ...
When Stigma Collapses
Mental health awareness—once relegated to advocacy days and reluctant disclosures—now sits inside earnings calls, human resources dashboards, and federal appropriations. ...
If the Wealthy Live to 120
Longevity science—once confined to academic gerontology and speculative Silicon Valley forums—has entered capital markets and clinical practice with unusual momentum. ...
When Illness Has No Lab Value
Across clinics and corporate offices, a growing number of Americans identify with chronic conditions that resist straightforward measurement: long COVID, ...
When Hormones Become Lifestyle
Testosterone replacement therapy and broader hormone optimization have migrated from endocrinology clinics into subscription platforms, influencer podcasts, and venture-backed telehealth ...
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more